Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Ron Dior who wrote (1097)	5/26/1998 10:37:00 PM
From: Jerel Zoltick	Read Replies (1) \| Respond to of 2135

ENMD is a 10 - 12 stock. In this market, people want a quick run in price. This stock has several years to prove itself; if successful it will be a very worth while stock in terms of price. Scientifically there is a lot going for the stock, but for the short term, the stock can be bounced all over the place. The trend will be down. I played the stock from 6s to the 50s and will re-enter when it re-treats again. Most investors, don't have any patience. From previous experience, the stock will gradually go down and if there is a quick deep correction the stock can fall as fast as it climbed. Remember the news of its cancer research has been around for months.......jmz

To: Ron Dior who wrote (1097)	5/26/1998 11:55:00 PM
From: Sr K	Read Replies (1) \| Respond to of 2135

<<then use the profit of your short to buy long term leaps>>??? No LEAPs short, long or any term, to my knowledge.